価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Tau441(2N4R), Active, P301S Mutant Protein PFFs, Human, Recombinant
データシート※最新のデータシートでない場合があります
SPR-329B STQストレスマークバイオサイエンス
StressMarq Biosciences Inc.
100 μg ¥95,000
(未発注)
追加

在庫・価格 : 2025年04月26日 08時45分 現在

Tau441(2N4R), Active, P301S Mutant Protein PFFs, Human, Recombinant

  • 商品コード:SPR-329B
  • メーカー:STQ
  • 包装:100μg
  • 価格: ¥95,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sandusky-Beltran LA et al. Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology. J Clin Invest 2021 02;131(4)
Sandusky-Beltran LA et al
2021/01/01
PubMed
2 Yang CC et al. Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice. Curr Med Sci 2020 Dec;40(6):1040-1046
Yang CC et al
2020/01/01
PubMed
3 McGregor ER et al. Reversal of neuronal tau pathology via adiponectin receptor activation. Commun Biol 2025 Jan;8(1):8
McGregor ER et al
2025/01/01
PubMed
4 Falkon KF et al. Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms. Alzheimers Dement 2025 Feb;21(2):e14418
Falkon KF et al
2025/01/01
PubMed
5 Kim DK et al. FGFR3 drives Aβ-induced tau uptake. Exp Mol Med 2024 Jul;56(7):1631-1642
Kim DK et al
2024/01/01
PubMed
6 McGregor ER et al. Reversal of neuronal tau pathology, metabolic dysfunction, and electrophysiological defects via adiponectin pathway-dependent AMPK activation. bioRxiv 2024 Feb;
McGregor ER et al
2024/01/01
PubMed
7 Chen Y et al. APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread. Cell 2024 Jan;187(2):428-445.e20
Chen Y et al
2024/01/01
PubMed
8 Desai AA et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv 2023 Jul;
Desai AA et al
2023/01/01
PubMed
9 Zupancic JM et al. Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates. Front Immunol 2023;14:1164080
Zupancic JM et al
2023/01/01
PubMed
10 Tan JX et al. A phosphoinositide signalling pathway mediates rapid lysosomal repair. Nature 2022 Sep;609(7928):815-821
Tan JX et al
2022/01/01
PubMed
11 Dong Q et al. Mutant &#x3B2;<sub>1</sub>-adrenergic receptor improves REM sleep and ameliorates tau accumulation in a mouse model of tauopathy. Proc Natl Acad Sci U S A 2023 Apr;120(15):e2221686120
Dong Q et al
2023/01/01
PubMed
  • No.: 1
  • 文献情報:
    Sandusky-Beltran LA et al. Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology. J Clin Invest 2021 02;131(4)
    Sandusky-Beltran LA et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yang CC et al. Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice. Curr Med Sci 2020 Dec;40(6):1040-1046
    Yang CC et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    McGregor ER et al. Reversal of neuronal tau pathology via adiponectin receptor activation. Commun Biol 2025 Jan;8(1):8
    McGregor ER et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Falkon KF et al. Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms. Alzheimers Dement 2025 Feb;21(2):e14418
    Falkon KF et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kim DK et al. FGFR3 drives A&#x3B2;-induced tau uptake. Exp Mol Med 2024 Jul;56(7):1631-1642
    Kim DK et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    McGregor ER et al. Reversal of neuronal tau pathology, metabolic dysfunction, and electrophysiological defects via adiponectin pathway-dependent AMPK activation. bioRxiv 2024 Feb;
    McGregor ER et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chen Y et al. APOE3ch alters microglial response and suppresses A&#x3B2;-induced tau seeding and spread. Cell 2024 Jan;187(2):428-445.e20
    Chen Y et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Desai AA et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv 2023 Jul;
    Desai AA et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zupancic JM et al. Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates. Front Immunol 2023;14:1164080
    Zupancic JM et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Tan JX et al. A phosphoinositide signalling pathway mediates rapid lysosomal repair. Nature 2022 Sep;609(7928):815-821
    Tan JX et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Dong Q et al. Mutant &#x3B2;<sub>1</sub>-adrenergic receptor improves REM sleep and ameliorates tau accumulation in a mouse model of tauopathy. Proc Natl Acad Sci U S A 2023 Apr;120(15):e2221686120
    Dong Q et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed